Effects on tumor development and metastatic dissemination by the NKG2D lymphocyte receptor expressed on cancer cells

被引:12
作者
El-Gazzar, A. [1 ]
Cai, X. [1 ]
Reeves, R. S. [1 ]
Dai, Z. [1 ]
Caballero-Benitez, A. [1 ]
McDonald, D. L. [1 ]
Vazquez, J. [1 ]
Gooley, T. A. [1 ]
Sale, G. E. [1 ]
Spies, T. [1 ]
Groh, V. [1 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98112 USA
基金
奥地利科学基金会;
关键词
NKG2D receptor; breast cancer; xenotransplant; angiogenesis; metastasis; NK CELLS; T-CELLS; ACTIVATION; LIGANDS; INHIBITION; APOPTOSIS; GROWTH; MICA;
D O I
10.1038/onc.2013.435
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The stimulatory NKG2D lymphocyte receptor together with its tumor-associated ligands enable the immune system to recognize and destroy cancer cells. However, with dynamic changes unfolding, cancers exploit NKG2D and its ligands for immune evasion and suppression. Recent findings have added yet another functional dimension, wherein cancer cells themselves co-opt NKG2D for their own benefit to complement the presence of its ligands for self-stimulation of parameters of tumorigenesis. Those findings are here extended to in vivo tumorigenicity testing by employing orthotopic xenotransplant breast cancer models in mice. Using human cancer lines with ectopic NKG2D expression and RNA interference (RNAi)-mediated protein depletion among other controls, we show that NKG2D self-stimulation has tumor-promoting capacity. NKG2D signals had no notable effects on cancer cell proliferation and survival but acted at the level of angiogenesis, thus promoting tumor growth, tumor cell intravasation and dissemination. NKG2D-mediated effects on tumor initiation may represent another factor in the observed overall enhancement of tumor development. Altogether, these results may have an impact on immunotherapy approaches, which currently do not account for such NKG2D effects in cancer patients and thus could be misdirected as underlying assumptions are incomplete.
引用
收藏
页码:4932 / 4940
页数:9
相关论文
共 21 条
[1]   Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J].
Bauer, Stefan ;
Groh, Veronika ;
Wu, Jun ;
Steinle, Alexander ;
Phillips, Joseph H. ;
Lanier, Lewis L. ;
Spies, Thomas .
JOURNAL OF IMMUNOLOGY, 2018, 200 (07) :2231-2233
[2]   Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasis [J].
Ben-Batalla, Isabel ;
Seoane, Samuel ;
Garcia-Caballero, Tomas ;
Gallego, Rosalia ;
Macia, Manuel ;
Gonzalez, Luis O. ;
Vizoso, Francisco ;
Perez-Fernandez, Roman .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (12) :4289-4302
[3]   Expression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells [J].
Benitez, Andrea Caballero ;
Dai, Zhenpeng ;
Mann, Henning H. ;
Reeves, Rebecca S. ;
Margineantu, Daciana H. ;
Gooley, Ted A. ;
Groh, Veronika ;
Spies, Thomas .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (10) :4081-4086
[4]   Delivery of NKG2D Ligand Using an Anti-HER2 Antibody-NKG2D Ligand Fusion Protein Results in an Enhanced Innate and Adaptive Antitumor Response [J].
Cho, Hyun-Mi ;
Rosenblatt, Joseph D. ;
Tolba, Khaled ;
Shin, Sarah J. ;
Shin, Daniel S. ;
Calfa, Carmen ;
Zhang, Yu ;
Shin, Seung-Uon .
CANCER RESEARCH, 2010, 70 (24) :10121-10130
[5]   Promiscuity and the single receptor: NKG2D [J].
Eagle, Robert A. ;
Trowsdale, John .
NATURE REVIEWS IMMUNOLOGY, 2007, 7 (09) :737-744
[6]  
González S, 2006, CURR TOP MICROBIOL, V298, P121
[7]   Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB [J].
Groh, V ;
Rhinehart, R ;
Secrist, H ;
Bauer, S ;
Grabstein, KH ;
Spies, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6879-6884
[8]   PI3K/PTEN Signaling in Angiogenesis and Tumorigenesis [J].
Jiang, Bing-Hua ;
Liu, Ling-Zhi .
ADVANCES IN CANCER RESEARCH, VOL 102, 2009, 102 :19-65
[9]  
KAUFMANN SH, 1993, CANCER RES, V53, P3976
[10]   Regulation of apoptosis by insulin-like growth factor (IGF)-I [J].
Kooijman, Ron .
CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (04) :305-323